Paul Peter Tak - 28 Nov 2023 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Jason Amello, as Attorney-in-Fact for Paul Peter Tak
Issuer symbol
CADL
Transactions as of
28 Nov 2023
Net transactions value
-$39,099
Form type
4
Filing time
30 Nov 2023, 17:00:17 UTC
Previous filing
28 Nov 2023
Next filing
15 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Tax liability $39,099 -43,443 -10% $0.9000 373,556 28 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units.